E-011 Factors influencing thrombectomy decision-making for primary medium vessel occlusion stroke

ConclusionsMost physicians in this survey would treat MeVO stroke patients immediately with EVT, supporting the need for more robust clinical evidence.Disclosures P. Cimflova: None. M. Kappelhof: None. N. Singh: None. N. Kashani: None. J. Ospel: None. R. McDonough: None. A. Demchuk: None. B. Menon: None. N. Sakai: None. M. Chen: 2; C; Medtronic, Genentech, Stryker, Microvention, Cerenovus, Penumbra. J. Fiehler: 1; C; Acandis, Medtronic, Microvention, Stryker. 2; C; Acandis, Codman, Cerenovus, Microvention, Medtronic, Penumbra, Phenox, Stryker. M. Goyal: 2; C; Medtronic, Microvention, Stryker, GE Healthcare, Mentice.

Source: Journal of NeuroInterventional Surgery - July 26, 2021 Category: Neurosurgery Authors: Cimflova, P., Kappelhof, M., Singh, N., Kashani, N., Ospel, J., McDonough, R., Demchuk, A., Menon, B., Sakai, N., Chen, M., Fiehler, J., Goyal, M. Tags: Electronic poster abstracts Source Type: research